Riskpilot← Back to searchSign inGet full accessSendoline AB
ABDissolvedOrg 5560514886Manufacture of medical and dental instruments and supplies · NACE 3250Est. 194810 employees
Revenue 2020
SEK 38,3M
-7% vs 2019
EBITDA margin
-1.4%
-156% vs 2019
Equity ratio
68.8%
Financial strength
Net profit 2020
SEK -930K
-281% vs 2019
| Revenue | SEK 38,3M | -7% |
| EBITDA | SEK -549K | -156% |
| Net profit | SEK -930K | -281% |
| Total assets | SEK 17,5M | -17% |
| Equity | SEK 12M | -33% |
| Employees | 10 | — |
Legal name
Sendoline AB
Org number
5560514886
Legal form
Aktiebolag
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
5 januari 1948
Share capital
SEK 0
Employees
10 (FTE)
VAT registered
No
Audit selected
No
Last report
2020-08-31
Financial year
January – December
Company purpose
Bolaget ska bedriva tillverkning och handel inom dentalbranschen och därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|
| Revenue | 35 168 | 46 301 | 40 180 | 41 176 | 38 301 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −599 | 2 323 | −394 | 983 | −549 |
| Depreciation & amort. | −103 | −308 | −308 | −308 | −347 |
| EBIT | −702 | 2 015 | −702 | 675 | −896 |
| Net financials | 5 452 | −72 | −24 | −34 | −34 |
| Profit before tax | 5 575 | 1 593 | −376 | 641 | −930 |
| Tax | −0 | −258 | −0 | −127 | −0 |
| Net profit | 5 575 | 1 335 | −376 | 514 | −930 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|
| Total assets | 22 187 | 26 885 | 20 623 | 21 185 | 17 484 |
| Equity | 18 987 | 17 822 | 17 446 | 17 960 | 12 030 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 3 200 | 8 713 | 3 177 | 3 224 | 5 454 |
| Total debt | 3 200 | 8 713 | 3 177 | 3 224 | 5 454 |
EBITDA margin
-1.4%
This company
15.8%
Market median
-109% vs market
20162020
Equity ratio
68.8%
This company
38.2%
Market median
+80% vs market
20162020
Return on equity
-7.7%
This company
18.4%
Market median
-142% vs market
20162020
Net profit margin
-2.4%
This company
8.1%
Market median
-130% vs market
20162020
Asset turnover
2.19×
This company
1.12×
Market median
+96% vs market
20162020
Debt / equity
0.45×
This company
0.62×
Market median
+27% vs market
20162020
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-09-01 – 2020-08-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-09-01 – 2019-08-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-09-01 – 2018-08-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-09-01 – 2017-08-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-09-01 – 2016-08-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HC Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
PJ Chief Auditor | Chief Auditor | 2021 | — | — |
IH Chief Auditor | Chief Auditor | 2021 | — | — |
PW Audit | Audit | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Chairman | 2021 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Sendoline AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Henric Carl Evert Karsk | Chief Executive Officer | 0 companies |
| Peter Johan Kjörnsberg | Chief Auditor | 0 companies |
| Ingegerd Helena Elisabet Degerstedt Jakobsson | Chief Auditor | 0 companies |
| Patricie Weis | Audit | 0 companies |
| Tomas Henry Skeppmark | Board of Directors | 0 companies |
| Maria Ulrika Hallén Tabrizi | Deputy Board Member | 0 companies |
| Erik Tomas Hoffman | Chairman | 0 companies |